pamidronate has been researched along with Muscle Disorders in 1 studies
Excerpt | Relevance | Reference |
---|---|---|
"Pamidronate at 60 mg was compared with pamidronate at 10 mg rather than placebo in view of the high incidence of transient arthralgias upon first IV exposure to the drug." | 5.10 | A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis. ( Aaron, SL; Chiu, P; Davis, P; Fitzgerald, AA; Homik, J; Jhangri, GS; LeClercq, S; Maksymowych, WP; Russell, AS; Sholter, D; Skeith, KJ; Yan, A, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Maksymowych, WP | 1 |
Jhangri, GS | 1 |
Fitzgerald, AA | 1 |
LeClercq, S | 1 |
Chiu, P | 1 |
Yan, A | 1 |
Skeith, KJ | 1 |
Aaron, SL | 1 |
Homik, J | 1 |
Davis, P | 1 |
Sholter, D | 1 |
Russell, AS | 1 |
1 trial available for pamidronate and Muscle Disorders
Article | Year |
---|---|
A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Diphosphonates | 2002 |